Dynamin is required for recombinant adeno-associated virus type 2 infection

D Duan, Q Li, AW Kao, Y Yue, JE Pessin… - Journal of …, 1999 - Am Soc Microbiol
D Duan, Q Li, AW Kao, Y Yue, JE Pessin, JF Engelhardt
Journal of virology, 1999Am Soc Microbiol
Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders
have demonstrated considerable potential for molecular medicine. Recent identification of
the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain
organs may demonstrate higher efficiencies of gene transfer with this vector. However, the
mechanisms by which AAV-2 enters cells remain unknown. In the present report, we have
examined whether the endocytic pathways of rAAV-2 are dependent on dynamin, a GTPase …
Abstract
Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders have demonstrated considerable potential for molecular medicine. Recent identification of the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain organs may demonstrate higher efficiencies of gene transfer with this vector. However, the mechanisms by which AAV-2 enters cells remain unknown. In the present report, we have examined whether the endocytic pathways of rAAV-2 are dependent on dynamin, a GTPase protein involved in clathrin-mediated internalization of receptors and their ligands from the plasma membrane. Using a recombinant adenovirus expressing a dominant-inhibitory form of dynamin I (K44A), we have demonstrated that rAAV-2 infection is partially dependent on dynamin function. Overexpression of mutant dynamin I significantly inhibited AAV-2 internalization and gene delivery, but not viral binding. Furthermore, colocalization of rAAV and transferrin in the same endosomal compartment provides additional evidence that clathrin-coated pits are the predominant pathway for endocytosis of AAV-2 in HeLa cells.
American Society for Microbiology